Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 160,364,576
  • Shares Outstanding, K 5,666,593
  • Annual Sales, $ 58,496 M
  • Annual Income, $ 2,119 M
  • 60-Month Beta 0.63
  • Price/Sales 2.80
  • Price/Cash Flow 9.70
  • Price/Book 1.77
Trade PFE with:

Options Overview Details

View History
  • Implied Volatility 25.42% ( +3.87%)
  • Historical Volatility 29.17%
  • IV Percentile 56%
  • IV Rank 46.62%
  • IV High 33.73% on 10/27/23
  • IV Low 18.16% on 05/13/24
  • Put/Call Vol Ratio 0.92
  • Today's Volume 119,585
  • Volume Avg (30-Day) 234,021
  • Put/Call OI Ratio 0.94
  • Today's Open Interest 2,941,873
  • Open Int (30-Day) 3,109,651

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.45
  • Number of Estimates 7
  • High Estimate 0.54
  • Low Estimate 0.32
  • Prior Year 0.67
  • Growth Rate Est. (year over year) -32.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.54 +10.81%
on 04/29/24
29.63 -4.49%
on 05/22/24
+2.90 (+11.42%)
since 04/26/24
3-Month
25.20 +12.30%
on 04/26/24
29.63 -4.49%
on 05/22/24
+1.26 (+4.66%)
since 02/28/24
52-Week
25.20 +12.30%
on 04/26/24
40.37 -29.89%
on 06/13/23
-9.30 (-24.73%)
since 05/26/23

Most Recent Stories

More News
2 Beaten-Down Dividend Stocks Near 52-Week Lows. Should You Buy the Dips?

The major market indexes keep hitting new highs, but these stocks haven't participated in the bull run.

CI : 333.21 (+0.18%)
PFE : 28.30 (-2.01%)
WBA : 15.38 (-4.05%)
Got $500? 3 Pharma Stocks to Buy and Hold Forever

These players might even beat the market when the conditions are right.

VRTX : 446.88 (-2.20%)
LLY : 807.86 (+0.05%)
PFE : 28.30 (-2.01%)
This Stock Has Gained 150% Since I Bought It – but It Could Still Be a Bargain

I bought this bank stock during the initial COVID-19 crash, and I'm sure glad I did.

WFC : 59.48 (-1.21%)
PFE : 28.30 (-2.01%)
How Much Will Pfizer Pay Out in Dividends This Year?

As one of the world's largest drugmakers, Pfizer generates lots of cash it can share with investors.

PFE : 28.30 (-2.01%)
1 No-Brainer Dividend Stock Yielding More Than 5% to Buy and Hold Forever

Going against the grain here looks like a great idea.

WBA : 15.38 (-4.05%)
PFE : 28.30 (-2.01%)
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:RENB),(NASDAQ:CYTO),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END

ONCY : 1.1000 (+0.92%)
ONC.TO : 1.49 (-2.61%)
RENB : 1.4700 (+3.52%)
CYTO : 1.6100 (-9.55%)
PFE : 28.30 (-2.01%)
ABBV : 155.34 (-1.10%)
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032

ONCY : 1.1000 (+0.92%)
ONC.TO : 1.49 (-2.61%)
RENB : 1.4700 (+3.52%)
CYTO : 1.6100 (-9.55%)
PFE : 28.30 (-2.01%)
ABBV : 155.34 (-1.10%)
Why Vaccine Stocks Rallied This Week

A bird flu outbreak could spur demand for vaccines from these key players, but is it likely?

SNY : 47.94 (-1.24%)
MRNA : 153.20 (-8.05%)
NVAX : 15.52 (+0.10%)
BNTX : 94.10 (-2.94%)
PFE : 28.30 (-2.01%)
3 Stocks That Can Help You to Get Richer in 2025 and Beyond

These are three solid contenders for your portfolio.

PFE : 28.30 (-2.01%)
VEEV : 203.09 (-0.39%)
VOO : 487.12 (+0.08%)
New report from Access to Medicine Foundation shows what pharma companies can do to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance

/CNW/ -- The race to create replacement antibiotics and antifungals to combat superbugs is falling dangerously short, putting people across the world at risk....

PFE : 28.30 (-2.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 29.49
2nd Resistance Point 29.19
1st Resistance Point 28.74
Last Price 28.30
1st Support Level 27.99
2nd Support Level 27.69
3rd Support Level 27.24

See More

52-Week High 40.37
Fibonacci 61.8% 34.57
Fibonacci 50% 32.78
Fibonacci 38.2% 30.99
Last Price 28.30
52-Week Low 25.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar